G-25671

Overview

G-25671 is a platelet cyclooxygenase ( COX ) inhibitor ( K i = 4.5 μM) and uricosuric agent, as well as the active metabolite of Sulfinpyrazone ( HY-B1271 ). G-25671 reduces the production of thromboxane B 2 and malondialdehyde from arachidonic acid (AA), and inhibits human platelet aggregation induced by Sodium arachidonate ( HY-109590A ). G-25671 can be used in gout-related research.

Application

Products | Products > Disease Areas > Purine Metabolism | Products > Disease Areas > Gout | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Arthritis | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > COX | Products > Signaling Pathways > Drug Metabolite

Product Information

• Catalog No.: HY-W551882
• CAS No.: 3736-92-3
• Molecular Formula: C23H20N2O2S
• Molecular Weight: 388.49
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source